Syndax Pharmaceuticals Inc’s recently made public that its Chief Financial Officer Goldan Keith A. unloaded Company’s shares for reported $12033.0 on Jul 16 ’25. In the deal valued at $9.29 per share,1,296 shares were sold. As a result of this transaction, Goldan Keith A. now holds 92,450 shares worth roughly $0.95 million.
Then, Metzger Michael A sold 7,534 shares, generating $69,953 in total proceeds. Upon selling the shares at $9.29, the Chief Executive Officer now owns 298,661 shares.
Before that, Goldan Keith A. bought 1,296 shares. Syndax Pharmaceuticals Inc shares valued at $12,034 were divested by the Officer at a price of $9.29 per share.
Goldman initiated its Syndax Pharmaceuticals Inc [SNDX] rating to a Buy in a research note published on July 10, 2025; the price target was $18. A number of analysts have revised their coverage, including UBS’s analysts, who began to cover the stock in late October with a ‘”a Buy”‘ rating. Jefferies began covering SNDX with “Buy” recommendation on June 28, 2024. Scotiabank revised its rating on January 31, 2024. It rated SNDX as “a Sector perform” which previously was an “a Sector outperform”.
Price Performance Review of SNDX
On Tuesday, Syndax Pharmaceuticals Inc [NASDAQ:SNDX] saw its stock jump 5.96% to $10.31. Over the last five days, the stock has gained 11.94%. Syndax Pharmaceuticals Inc shares have fallen nearly -55.60% since the year began. Nevertheless, the stocks have fallen -22.01% over the past one year. While a 52-week high of $25.07 was reached on 02/21/25, a 52-week low of $8.58 was recorded on 05/15/25.
Levels Of Support And Resistance For SNDX Stock
The 24-hour chart illustrates a support level at 9.87, which if violated will result in even more drops to 9.43. On the upside, there is a resistance level at 10.56. A further resistance level may holdings at 10.81.
How much short interest is there in Syndax Pharmaceuticals Inc?
A steep rise in short interest was recorded in Syndax Pharmaceuticals Inc stocks on 2025-06-30, growing by 0.73 million shares to a total of 23.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-05-30 was 23.14 million shares. There was a rise of 3.05%, which implies that there is a positive sentiment for the stock.
The most recent change occurred on December 22, 2023 when Mizuho began covering the stock and recommended ‘”a Buy”‘ rating along with a $45 price target.
